编辑推荐

  • img

    Review

    Genomic instability and eye diseases

    Background

    Genetic information is stored in the bases of double-stranded DNA. However, the integrity of DNA molecules is constantly threatened by various mutagenic agents, including pollutants, ultraviolet light (UV), and medications. To counteract these environmental damages, cells have established multiple mechanisms, such as producing molecules to identify and eliminate damaged DNA, as well as reconstruct the original DNA structures. Failure or insufficiency of these mechanisms can cause genetic instability. However, the role of genome stability in eye diseases is still under-researched, despite extensive study in cancer biology.

    Main text

    As the eye is directly exposed to the external environment, the genetic materials of ocular cells are constantly under threat. Some of the proteins essential for DNA damage repair, such as pRb, p53, and RAD21, are also key during the ocular disease development. In this review, we discuss five ocular diseases that are associated with genomic instability. Retinoblastoma and pterygium are linked to abnormal cell cycles. Fuchs’ corneal endothelial dystrophy and age-related macular degeneration are related to the accumulation of DNA damage caused by oxidative damage and UV. The mutation of the subunit of the cohesin complex during eye development is linked to sclerocornea.

    Conclusions

    Failure of DNA damage detection or repair leads to increased genomic instability. Deciphering the role of genomic instability in ocular diseases can lead to the development of new treatments and strategies, such as protecting vulnerable cells from risk factors or intensifying damage to unwanted cells.
    2023-11-15
  • img

    Review

    Genetic and epigenetic regulators of retinal Müller glial cell reprogramming

    Background

    Retinal diseases characterized with irreversible loss of retinal nerve cells, such as optic atrophy and retinal degeneration, are the main causes of blindness. Current treatments for these diseases are very limited. An emerging treatment strategy is to induce the reprogramming of Müller glial cells to generate new retinal nerve cells, which could potentially restore vision.

    Main text

    Müller glial cells are the predominant glial cells in retinae and play multiple roles to maintain retinal homeostasis. In lower vertebrates, such as in zebrafish, Müller glial cells can undergo cell reprogramming to regenerate new retinal neurons in response to various damage factors, while in mammals, this ability is limited. Interestingly, with proper treatments, Müller glial cells can display the potential for regeneration of retinal neurons in mammalian retinae. Recent studies have revealed that dozens of genetic and epigenetic regulators play a vital role in inducing the reprogramming of Müller glial cells in vivo. This review summarizes these critical regulators for Müller glial cell reprogramming and highlights their differences between zebrafish and mammals.

    Conclusions

    A number of factors have been identified as the important regulators in Müller glial cell reprogramming. The early response of Müller glial cells upon acute retinal injury, such as the regulation in the exit from quiescent state, the initiation of reactive gliosis, and the re-entry of cell cycle of Müller glial cells, displays significant difference between mouse and zebrafish, which may be mediated by the diverse regulation of Notch and TGFβ (transforming growth factor-β) isoforms and different chromatin accessibility.
    2023-11-15
  • img

    Review

    Research progress of iron metabolism in retinal diseases

    Background

    Retinal diseases can lead to severe visual impairment and even blindness, but current treatments are limited. For precise targeted therapy, the pathophysiological mechanisms of the diseases still need to be further explored. Iron serves an essential role in many biological activities and helps maintain the function and morphology of the retina. The vision problems caused by retinal diseases are affecting more and more people, the study of iron metabolism in retinal diseases possesses great potential for clinical application.

    Main text

    Iron maintains a dynamic balance in the retina but in excess is toxic to the retina. Iron overload can lead to various pathological changes in the retina through oxidative stress, inflammation, cell death, angiogenesis and other pathways. It is therefore involved in the progression of retinal diseases such as age-related macular degeneration, glaucoma, diabetic retinopathy, retinitis pigmentosa, and hereditary iron overload. In recent years, iron chelators have been shown to be effective in the treatment of retinal diseases, but the exact mechanism is not yet fully understood. This question prompted further investigation into the specific mechanisms by which iron metabolism is involved in retinal disease.

    Conclusions

    This review summarizes iron metabolism processes in the retina and mechanistic studies of iron metabolism in the progression of retinal disease. It also highlights the therapeutic potential of iron chelators in retinal diseases.
    2023-11-15
  • img

    Artificial intelligence and deep learning in ophthalmology: Current status and future perspectives

    Background

    The ophthalmology field was among the first to adopt artificial intelligence (AI) in medicine. The availability of digitized ocular images and substantial data have made deep learning (DL) a popular topic.

    Main text

    At the moment, AI in ophthalmology is mostly used to improve disease diagnosis and assist decision-making aiming at ophthalmic diseases like diabetic retinopathy (DR), glaucoma, age-related macular degeneration (AMD), cataract and other anterior segment diseases. However, most of the AI systems developed to date are still in the experimental stages, with only a few having achieved clinical applications. There are a number of reasons for this phenomenon, including security, privacy, poor pervasiveness, trust and explainability concerns.

    Conclusions

    This review summarizes AI applications in ophthalmology, highlighting significant clinical considerations for adopting AI techniques and discussing the potential challenges and future directions.
    2023-11-15
加载中...

眼科实践与研究新进展

  • 主管单位: 教育部
  • 主办单位: 浙江大学，浙江大学医学院附属第二医院
  • 主编: 姚 克 共同主编:  Richard Abbott ISSN: 2667-3762
  • 出版周期: 季刊
  • 电话: +86-0571-8731 7715
  • 邮箱: aopr@zju.edu.cn
  •  

 

精选视频

  • AOPR期刊主编访谈 00:04:25

    AOPR期刊主编访谈

    2023-11-13
    播放量： 8
查看更多

最新论文

加载中...
更多 >

期刊介绍

期刊介绍
  • 期刊介绍 期刊介绍
  • 编委会 编委会
  • 期刊公告 期刊公告
  • 眼科资讯 眼科资讯

文章在线

文章在线
  • 编辑推荐 编辑推荐
  • 优先出版 优先出版
  • 当期目次 当期目次
  • 过刊浏览 过刊浏览
  • 虚拟专辑 虚拟专辑

作者服务

作者服务
  • 投稿须知 投稿须知
  • OA政策了解 OA政策了解
  • 稿件状态查询 稿件状态查询
  • 下载中心 下载中心

联系我们

电话：+86-0571-8731 7715

邮箱：aopr@zju.edu.cn

地址：浙江省杭州市上城区西湖大道1号浙江大学眼科医院/浙江大学医学院第二附属医院眼科中心7楼AOPR编辑部

 

0